Receive funding for your R&D Projects!
Your partner for subsidy advice
Your partner for subsidy advice
Non-smokers who are exposed to environmental tobacco smoke for at least 30 minutes a day are at far greater risk of developing acute coronary syndromes compared with people who are not exposed, finds a study in Tobacco Control.
These findings support the role of environmental tobacco smoke in the development of adverse cardiac events.
A total of 847 individuals with a first event of acute coronary syndromes and 1,078 cardiovascular disease-free controls were included in the study. P
Every morning millions of Americans reach for the world’s most popular drug to help them start their day.
“That drug is caffeine,” said Dr. James Bibb, assistant professor of psychiatry at UT Southwestern Medical Center at Dallas. Bibb is one of the authors of a new report explaining how caffeine exerts its stimulatory effect by altering the biochemistry of the brain. The findings appear in an August issue of Nature.
“Caffeine is the most frequently self-administered dru
Answer revealed in glowing live cells
Using a new mouse model that literally glows with health- protecting molecules, researchers have rewritten part of the textbook tale about how the immune system knows when to fight germs.
Time-lapse video from a pair of Harvard Medical School labs shows how pieces of captured germs may work their way to the surface of live dendritic cells. Dendritic cells are immune cells that alert other immune cells about invading germs. Inside a dendri
Protein phosphatase 1 (PP1) belongs to a group of molecules that on the basis of earlier studies has been proposed to be a controlling factor for learning and memory. The ETH researchers produced genetically modified mice in which the activity of PP1 can be reduced at will. These animals were subjected to various learning and memory tests in one of which, the mice had to learn about various objects in a box. For this, they were trained on different schedules: without any interruption during learning
The production of fusion energy with a PetaWatt laser is a step closer now that a team of scientists from Japan and the UK has demonstrated that the physics works. Using the GEKKO XII laser system at the Osaka University in Japan, the team has successfully conducted experiments at laser powers equivalent to those required for a full-scale ignition system, and the results will be published in Nature on Thursday 29 August 2002.
“We carried out a first “proof of principle” experiment in 2001 th
Rush is one of only two sites in nation testing the drug that may provide new treatment option
Physicians at Rush-Presbyterian St. Luke’s Medical Center have begun to recruit patients as part of a clinical research study that will evaluate the effectiveness of a new drug as a potential treatment for fragile X syndrome and autism.
The trials are taking place at Rush and the University of California, Davis. The principal investigators in the study are Dr. Elizabeth Berry-Krav